Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Affirm Holdings Inc (AFRM) vs ResMed Inc. (RMD) Price & Performance

Affirm Holdings IncTrade
ResMed Inc.Trade

Price performance (Past 24H)

Key statistics

Affirm Holdings Inc vs ResMed Inc. — how do they compare? Affirm Holdings Inc trades at $77.14 (market cap $25.30B), while ResMed Inc. trades at $223.62 (market cap $31.92B). The key difference: ResMed Inc. is the larger of the two by market cap, and ResMed Inc. pays a 1.2% dividend while Affirm Holdings Inc pays none. Which is the better fit depends on your goals.

AFRMRMD
Market Cap
$25.30B$31.92B
Sector
FinancialsHealth
52-Week High
$92.18$293.73
52-Week Low
$42.53$182.82
Enterprise Value
$31.91B$31.28B
Dividend Yield
1.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Affirm Holdings Inc

AFRM trades at $75.25, down 1.74% on the day, with a bullish technical signal supported by moving averages. The company reported strong revenue growth to $3.22B in 2025, turning profitable with net income of $52.19M, and has beaten EPS estimates in recent quarters. Positive sentiment is driven by analyst optimism and expanding merchant partnerships.

Outlook remains favorable with a consensus price target of $96.00, indicating 28% upside. Risks include high valuation multiples (P/E 68.41) and sensitivity to interest rate changes. Continued execution on growth and profitability will be key for stock performance.

ResMed Inc.

ResMed (RMD) trades at $211.94, down 5.06% on the day, following a Q4 2026 earnings beat but weaker fiscal 2027 revenue guidance. The stock shows strong fundamentals with a 26.94% net income margin and consistent earnings beats, while technical indicators are neutral with support at $204 and resistance at $218. Recent news highlights growth in sleep device demand but concerns over sales forecasts.

Outlook remains mixed: robust profitability and a $235 consensus price target suggest upside, but near-term pressure from guidance and technical neutrality poses risks. Investors should weigh solid financial health against market sentiment shifts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Affirm Holdings Inc

Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.

Read more on AFRM

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD